A guide to analytical approaches for characterizing antibody conjugates

9 Jun 2026

This guidebook explores analytical strategies for characterizing antibody conjugates, including antibody-drug conjugates (ADCs) and antibody oligonucleotide conjugates (AOCs). It highlights key chromatography and mass spectrometry techniques — such as hydrophobic interaction chromatography, size-exclusion chromatography, reversed-phase LC, and peptide mapping — to assess critical quality attributes including drug-to-antibody ratio, aggregation, and conjugation sites. The guide also examines emerging workflows for complex bioconjugates, supporting improved development, quality control, and regulatory readiness in biopharmaceutical research.

Resource details:

  • Resource type: Guidebook
  • Page count: 12 pages
  • Read time: 18 mins

BioResolve Columns

Waters

More than just a column -  A solution providing application-focused standards, methods, and exclusive support so you can easily and reliably achieve state-of-the-art separations.

(15)

Links

Tags

Mass SpectrometryMass spectrometry (MS) is a powerful analytical technique used to identify and quantify molecules based on the mass-to-charge ratio of gas-phase ions. It provides detailed information about the structure, composition, and properties of compounds and is widely used across fields such as environmental monitoring, materials science, drug discovery and development, food and beverage testing, and wider chemical research. Key MS techniques include tandem mass spectrometry (MS/MS), liquid chromatography–mass spectrometry (LS-MS) and inductively coupled plasma (ICP-MS). Choosing from these wide range of techniques and technologies can be a daunting task, so keep up to date with scientific applications, performance expectations, and customer reviews here all in one place. Visit our product directory to receive quotes direct from the manufacturer. Antibody Drug ConjugatesAntibody CharacterizationQCBiopharmaceuticalsBiopharmaceuticals are proteins and other compounds (such as nucleic acids) produced by living organisms that have uses as therapeutics or for in vivo diagnostics. The most well known example of a biopharmaceutical product, and the first to be approved for therapeutic use, was recombinant human insulin.